nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age as a Critical Determinant of Atrial Fibrillation: A Two-sided Relationship
|
Laredo, Mikael |
|
2018 |
34 |
11 |
p. 1396-1406 |
artikel |
2 |
Antithrombotic Therapy for Atrial Fibrillation and Coronary Disease Demystified
|
Andrade, Jason G. |
|
2018 |
34 |
11 |
p. 1426-1436 |
artikel |
3 |
Atrial Fibrillation and Heart Failure: Untangling a Modern Gordian Knot
|
Skanes, Allan C. |
|
2018 |
34 |
11 |
p. 1437-1448 |
artikel |
4 |
Data Linking Diabetes Mellitus and Atrial Fibrillation—How Strong Is the Evidence? From Epidemiology and Pathophysiology to Therapeutic Implications
|
Şerban, Răzvan C. |
|
2018 |
34 |
11 |
p. 1492-1502 |
artikel |
5 |
Editorial Board
|
|
|
2018 |
34 |
11 |
p. A1-A2 |
artikel |
6 |
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
|
Andrade, Jason G. |
|
2018 |
34 |
11 |
p. 1371-1392 |
artikel |
7 |
Information for Readers
|
|
|
2018 |
34 |
11 |
p. A8 |
artikel |
8 |
Insights on Atrial Fibrillation in Congenital Heart Disease
|
Ebrahim, Mohammad A. |
|
2018 |
34 |
11 |
p. 1531-1533 |
artikel |
9 |
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?
|
Tarride, Jean-Eric |
|
2018 |
34 |
11 |
p. 1522-1525 |
artikel |
10 |
Managing Direct Oral Anticoagulants in Patients With Antiepileptic Medication
|
Dagan, Gil |
|
2018 |
34 |
11 |
p. 1534.e1-1534.e3 |
artikel |
11 |
Mechanisms and Clinical Significance of Arrhythmia-Induced Cardiomyopathy
|
Raymond-Paquin, Alexandre |
|
2018 |
34 |
11 |
p. 1449-1460 |
artikel |
12 |
New Insights Into the Use of Cardiac Magnetic Resonance Imaging to Guide Decision Making in Atrial Fibrillation Management
|
Zghaib, Tarek |
|
2018 |
34 |
11 |
p. 1461-1470 |
artikel |
13 |
Persistent Atrial Fibrillation Ablation: Where Do We Go From Here?
|
Verma, Atul |
|
2018 |
34 |
11 |
p. 1471-1481 |
artikel |
14 |
Table of Contents
|
|
|
2018 |
34 |
11 |
p. A5-A7 |
artikel |
15 |
Taking the Pulse of Atrial Fibrillation: A Practical Approach to Rate Control
|
Aguilar, Martin |
|
2018 |
34 |
11 |
p. 1526-1530 |
artikel |
16 |
Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?
|
Wyse, D. George |
|
2018 |
34 |
11 |
p. 1393-1395 |
artikel |
17 |
The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations
|
Wan, Douglas |
|
2018 |
34 |
11 |
p. 1412-1425 |
artikel |
18 |
The Impact of Cardiac Rehabilitation on Mental and Physical Health in Patients With Atrial Fibrillation: A Matched Case-Control Study
|
Reed, Jennifer L. |
|
2018 |
34 |
11 |
p. 1512-1521 |
artikel |
19 |
The Importance and Future of Population Screening for Atrial Fibrillation
|
Shin, Seung Yong |
|
2018 |
34 |
11 |
p. 1407-1411 |
artikel |
20 |
The Multiple Causes of Stroke in Atrial Fibrillation: Thinking Broadly
|
D’Souza, Atlantic |
|
2018 |
34 |
11 |
p. 1503-1511 |
artikel |
21 |
When Is a Maze Procedure a Maze Procedure?
|
Cox, James L. |
|
2018 |
34 |
11 |
p. 1482-1491 |
artikel |